Atlas Trials

Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation

Clinical trial NCT07699796 · COMPLETED

Trial details

NCT number
NCT07699796
Sponsor
Heart, Artery, and Vein Center of Fresno
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Venous Thrombosis Deep (Limbs)Venous Insufficiency (Chronic)(Peripheral)Varicose Veins LegVenous Thrombosis
Start date
2018-03-06
Primary completion
2020-11-04
Enrollment
564

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.